Authors : Shashank Bhargava, Siddhartha Chakrabarty, Rajan T Damodaran, Prasanna Kumar Saikia, Manjunath Shenoy, Nikhil Bangale, Poonam Shah
DOI : 10.18231/j.ijced.2023.001
Volume : 9
Issue : 1
Year : 2023
Page No : 1-16
Cutaneous dermatophytosis are among the most common infections seen in clinical practice. Over the past few years there has been a rising trend in the prevalence with change in spectrum of infection and isolation of some uncommon species. Recognition and appropriate treatment of these infections is important to reduce the morbidity and discomfort and also reduce the possibility of transmission. Azoles are the antifungal agents used extensively to treat dermatophytosis. Clotrimazole is mainly used locally in the treatment of skin fungal infections due to dermatophytes and yeasts. It is known to provide a broad-spectrum antifungal coverage against dermatophytes, moulds, yeasts and some bacteria, and is an efficient, safe and well accepted treatment for skin fungal infections in children and adults. This review provides an overview of the role of topical clotrimazole available as cream and powder and in combination with topical steroid for the optimal management of skin fungal infections.
Keywords: Dermatophytosis, Superficial fungal infection, Tinea infections, Topical therapy, Antifungal agents, Clotrimazole